Announcement
Collapse
No announcement yet.
Treatments
Collapse
There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by tetano, March 11, 2021, 04:28 AM
|
0 responses
10 views
0 likes
|
Last Post
by tetano
March 11, 2021, 04:28 AM
|
||
|
News Release: Lilly's bamlanivimab and etesevimab together reduced hospitalizations and death in Phase 3 trial for early COVID-19
by Mary Wilson
Started by Mary Wilson, March 10, 2021, 03:20 PM
|
0 responses
19 views
0 likes
|
Last Post
by Mary Wilson
March 10, 2021, 03:20 PM
|
||
|
EClinicalMedicine . Hydroxychloroquine with or without azithromycin for treatment of early SARS-CoV-2 infection among high-risk outpatient adults: A randomized clinical trial
by tetano
Started by tetano, March 10, 2021, 06:50 AM
|
0 responses
19 views
0 likes
|
Last Post
by tetano
March 10, 2021, 06:50 AM
|
||
|
Pathog Glob Health . Phase 2 randomized study on chloroquine, hydroxychloroquine or ivermectin in hospitalized patients with severe manifestations of SARS-CoV-2 infection
by tetano
Started by tetano, March 10, 2021, 06:41 AM
|
0 responses
15 views
0 likes
|
Last Post
by tetano
March 10, 2021, 06:41 AM
|
||
|
Started by tetano, March 10, 2021, 06:28 AM
|
0 responses
14 views
0 likes
|
Last Post
by tetano
March 10, 2021, 06:28 AM
|
||
|
Br J Clin Pharmacol . Intestinal SGLT1 as a therapeutic target in COVID-19-related diabetes: A "two-edged sword" hypothesis
by tetano
Started by tetano, March 10, 2021, 05:22 AM
|
0 responses
10 views
0 likes
|
Last Post
by tetano
March 10, 2021, 05:22 AM
|
||
|
Started by tetano, March 10, 2021, 04:56 AM
|
0 responses
13 views
0 likes
|
Last Post
by tetano
March 10, 2021, 04:56 AM
|
||
|
Sci Rep . MRC5 cells engineered to express ACE2 serve as a model system for the discovery of antivirals targeting SARS-CoV-2
by tetano
Started by tetano, March 10, 2021, 04:55 AM
|
0 responses
16 views
0 likes
|
Last Post
by tetano
March 10, 2021, 04:55 AM
|
||
|
Front Med . Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trial
by tetano
Started by tetano, March 10, 2021, 04:30 AM
|
0 responses
13 views
0 likes
|
Last Post
by tetano
March 10, 2021, 04:30 AM
|
||
|
Started by tetano, March 8, 2021, 05:54 AM
|
0 responses
18 views
0 likes
|
Last Post
by tetano
March 8, 2021, 05:54 AM
|
No topics found.
-
Page of 0
-
Filter